Congress Takes Action on Critical Alzheimer’s Legislation to Ensure Addressing Alzheimer’s Remains a National Priority and Continue Momentum on Research Funding

Washington, D.C., May 16, 2022 — Today, the Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support the introduction of two bipartisan bills — the NAPA Reauthorization...

Read More

Congress Agrees on $289 Million Alzheimer’s Research Funding Increase and Robust Investment in Alzheimer’s Public Health Infrastructure

Washington, D.C., March 9, 2022 — Congressional leaders have announced a $289 million increase for Alzheimer's and dementia research funding at the National Institutes of Health (NIH) for fiscal year...

Read More

Alzheimer’s Association Statement on CMS Draft Decision

The following can be attributed to Harry Johns, Alzheimer's Association CEO: CHICAGO, January 11, 2022 — Today's draft decision by the Centers for Medicare & Medicaid Services (CMS) is shocking...

Read More

Alzheimer’s Association, Alzheimer’s Impact Movement Statement on the Death of Former Congressman Dennis Moore

Washington, D.C., November 3, 2021 - The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) were saddened to learn of the passing of former Rep. Dennis Moore. For more than a decade Rep...

Read More

Dr. Joanne Pike Named to National Alzheimer's Project Act Advisory Council

WASHINGTON, D.C., October 20, 2021 - The Department of Health and Human Services (HHS) has announced the appointment of Joanne Pike, Dr.PH, to the National Alzheimer's Project Act (NAPA) Advisory...

Read More

Alzheimer's Association, Alzheimer's Impact Movement Express Gratitude for Director Collins' NIH Leadership

Chicago, October 6, 2021 - The Alzheimer's Association and Alzheimer's Impact Movement (AIM) are immensely grateful for Francis S. Collins, M.D., Ph.D., who announced his decision to step down as...

Read More

National Institutes of Health Releases FY23 Professional Judgement Budget for Alzheimer's and Dementia Research Funding

WASHINGTON, D.C., July 19, 2021 - The National Institutes of Health (NIH) today released their annual professional judgement budget for Alzheimer's and dementia research, requesting an additional $226...

Read More

Critical Funding to Help End Alzheimer's Advances in the House Appropriations Subcommittee

WASHINGTON, D.C., July 14, 2021 - The House Appropriations Labor, Health and Human Services, Education, and Related Agencies Appropriations subcommittee has proposed a $200 million increase in...

Read More

The Equity in Neuroscience and Alzheimer's Clinical Trials (ENACT) Act Introduced in Congress

WASHINGTON, D.C., May 11, 2021 - The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support the bipartisan Equity in Neuroscience and Alzheimer's Clinical Trials (ENACT...

Read More

Bipartisan Legislation to Create a Path to Better Dementia Care Introduced

WASHINGTON, D.C., April 14, 2021 - The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support the bipartisan Comprehensive Care for Alzheimer's Act. Introduced by Sens...

Read More